What's Happening?
Morris Kahn, a Jewish billionaire and philanthropist, has been instrumental in advancing fertility preservation for women with cancer at Sheba Medical Center in Tel Hashomer. Over the past 18 years, Kahn's
involvement has led to the establishment of the world's largest center for fertility preservation in women with cancer. His contributions have supported the development of a dedicated laboratory focused on preventing the reintroduction of cancer cells through ovarian tissue transplantation. This initiative has resulted in the world's first safe ovarian transplant in a leukemia survivor, leading to successful pregnancies. Kahn's personal engagement and financial support have been pivotal in these medical advancements, with over 100 scientific papers published and numerous physicians trained at Sheba.
Why It's Important?
Kahn's contributions have significantly impacted the field of fertility preservation, offering hope to women with cancer who wish to have children post-treatment. The advancements at Sheba Medical Center set a global benchmark in safe ovarian transplantation, potentially influencing similar medical practices worldwide. This progress not only enhances the quality of life for cancer survivors but also positions Israel as a leader in fertility preservation research. The success of these initiatives underscores the importance of philanthropy in driving medical innovation and improving patient outcomes.
